Shea reports all four known activators sat deep in the receptor pocket while both blockers stayed farther out, the same pattern as his first small test.
Recap by typeshit. Post by Ryan Shea on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Asked whether injectable peptides or supplements are better, the poster says the first step either way is knowing the maker and what the product really contains.
Reuters reports the FDA has taken a formal step toward new rules for peptide compounding, a key development for pharmacies and the gray market alike.
Loading…